bromfenacoum and Infant--Newborn--Diseases

bromfenacoum has been researched along with Infant--Newborn--Diseases* in 1 studies

Other Studies

1 other study(ies) available for bromfenacoum and Infant--Newborn--Diseases

ArticleYear
Lethal neonatal coagulopathy after maternal ingestion of a superwarfarin.
    Obstetrics and gynecology, 2013, Volume: 122, Issue:2 Pt 2

    Brodifacoum, a superwarfarin, is a common household agent used for rodenticides. We present a case of maternal brodifacoum ingestion that resulted in neonatal death.. A 19-year-old primigravid woman presented at 32 weeks of gestation with spontaneous mucosal bleeding. Her fetus showed evidence of acidosis on external fetal monitoring. Laboratory values were consistent with maternal coagulopathy. After correction of the coagulopathy, the patient was taken for urgent cesarean delivery. The neonate showed evidence of fetal coagulopathy and died at 4 days of life.. Brodifacoum is a dangerous household chemical that, if ingested, can result in significant morbidity and mortality for both mother and neonate. Increased awareness of the serious and potentially lethal effects of brodifacoum is important.

    Topics: 4-Hydroxycoumarins; Adult; Anticoagulants; Blood Coagulation Disorders; Fatal Outcome; Female; Humans; Infant, Newborn; Infant, Newborn, Diseases; Maternal-Fetal Exchange; Pregnancy; Prenatal Exposure Delayed Effects; Rodenticides; Young Adult

2013